Cystic fibrosis-related diabetes testing in Grottaferrata
Find health labs to test for Cystic fibrosis-related diabetes in Grottaferrata and compare all offers by prices and services.
Hemoglobin Test by Casa di Cura Roma INI - GROTTAFERRATA
Strada Provinciale Sant'Anna in Grottaferrata, 00046 Grottaferrata RM, Italia
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Centro Raphael
Via Mattè Trucco, 00132 Roma RM, Italia
11.9 km
Diabetes Test by Bianalisi - Biosystem Group
Via Massa di San Giuliano, 229, 00132 Roma RM, Italia
11.9 km
Hemoglobin Test by Laboratorio Analisi Cliniche CE.DI.M.
Viale Partenope, 18, 00177 Roma RM, Italia
11.9 km
Diabetes Test by Casa di Cura Privata Madonna delle Grazie S.p.a.
Viale Salvo D'Acquisto, 67, 00049 Velletri RM, Italia
9 km
Diabetes Test by CDI Centro Diagnostico Italiano | Bionics Lavater - Porta Venezia
Via Tito Omboni, 8, 00147 Roma RM, Italia
11.9 km
Diabetes Test by Laboratorio Di Via Diego Angeli Srl
Via Diego Angeli, 173, 00159 Roma RM, Italia
11.9 km
Diabetes Test by Studio Medico Colombo - Analisi cliniche
Via Tiberio Imperatore, 19, 00145 Roma RM, Italia
11.9 km
Diabetes Test by Laboratorio Analisi Cliniche Giglioli srl - Poliambulatorio
Via Domenico De Dominicis, 39, 00159 Roma RM, Italia
11.9 km
Diabetes Test by Marilab Garbatella
Via Caffaro, 137, 00154 Roma RM, Italia
11.9 km
Diabetes Test by Lafarmacia.Tomaselli
Viale Beata Vergine del Carmelo, 75, 00144 Roma RM, Italia
11.9 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
